동물용 백신 시장 규모, 점유율, 동향 분석 보고서 : 동물 유형별, 제품별, 투여 경로별, 유통 채널별, 지역별, 부문별 예측(2025-2030년)

Animal Vaccines Market Size, Share & Trends Analysis Report By Animal Type (Livestock, Companion), By Product, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,609,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,950 ￦ 10,055,000

Printable PDF (5-User License)

PDF 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,950 ￦ 12,949,000

Printable PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

동물용 백신 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 동물용 백신 시장 규모는 2030년까지 229억 5,000만 달러에 이를 것으로 예상됩니다.

이 시장은 2025-2030년에 걸쳐 CAGR 9.5%로 확대될 것으로 예측됩니다. 식품을 매개로 하는 인수 공통 감염증 증가와 축산업 증가가 백신 수요를 밀어 올리고 있습니다. 또는 간접적으로 사람을 감염시킬 수 있습니다. 소비자가 가열 불충분한 물고기를 통해 지렁이를 먹으면 선충의 여러 종에 의해 유발되는 인류 공통 감염인 아니 사키스에 오염될 수 있습니다.

반추동물, 특히 소의 백신이 세계적으로 널리 받아들여지고 있는 주요 요인은 소의 질병 발생 증가와 늘어나는 가축두수입니다. 또한, 반려동물 사육 증가와 반려동물의 건강에 관한 의식 증가가 시장의 성장을 뒷받침하고 있습니다. 예측 기간 동안 시장 경쟁이 치열해질 것으로 예상됩니다.

게다가 기업은 시장에서 성장하기 위해 인수합병, 지리적 확대, 신제품 출시 등의 전략을 채택하는 경향이 강해지고 있습니다. 예를 들어, 엘랑코는 2020년 12월에 킨드레드 바이오사이언스로부터 개 파보바이러스(CPV)에 대한 단일 클론 항체(KIND-030)에 대한 글로벌 독점권을 획득했습니다.

동물용 백신 시장 보고서 하이라이트

• 약독생 백신 부문이 시장을 독점하고, 2024년에는 37.00% 이상의 매출 점유율을 차지했습니다.
• 축산 부문이 시장을 독점하고, 2024년의 수익 점유율이 가장 높았습니다.
• 병원/클리닉 약국은 2024년에 시장에서 압도적인 점유율을 차지했습니다. 이 시설은 신기술의 채용에 있어서 최전선에 서는 것이 많습니다.
• 2024년의 동물용 백신의 매출 점유율은 피하 투여형이 41.0%를 넘어 시장을 독점했습니다.
• 북미가 시장을 독점해 2024년의 매출 점유율은 28%를 넘었습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 동물용 백신 시장의 변동 동향과 전망

• 시장 계통의 전망
  • 상위 시장
  • 보조 시장
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
  • 시장 기회 분석
  • 시장 과제 분석
• 동물용 백신 시장 분석 도구
  • 산업 분석 - Porter's Five Forces 분석
  • PESTEL 분석
  • 규제 프레임워크
  • 가격 분석
  • 질병 유병률 분석
  • 주요 국가별, 주요종에 의한 동물 추정 개체수(2024년)
  • COVID-19의 영향 분석

제4장 동물용 백신 시장 : 동물 유형별, 추정·동향 분석

• 부문 대시보드
• 동물용 백신 시장 : 동물 유형 변동 분석
• 동물용 백신 시장 규모와 동향 분석(동물 유형별, 2018-2030년)
• 가축
  • 가금류
  • 수산
  • 반추동물
  • 돼지
• 반려동물
  • 개
  • 고양이
  • 기타

제5장 동물용 백신 시장 : 제품별, 추정·동향 분석

• 부문 대시보드
• 동물용 백신 시장 : 제품 변동 분석
• 동물용 백신 시장 규모와 동향 분석(제품별, 2018-2030년)
  • 약독화 생백신
  • 비활성화 백신
  • 서브 유닛 백신
  • DNA 백신
  • 재조합 백신

제6장 동물용 백신 시장 : 투여 경로별, 추정·동향 분석

• 부문 대시보드
• 동물용 백신 시장 : 투여 경로별 변동 분석
• 동물용 백신 시장 규모와 동향 분석(투여 경로별, 2018-2030년)
  • 피하
  • 근육 내
  • 비강 내

제7장 동물용 백신 시장 : 유통 채널별, 추정·동향 분석

• 부문 대시보드
• 동물용 백신 시장 : 유통 채널 변동 분석
• 동물용 백신 시장 규모와 동향 분석(유통 채널별, 2018-2030년)
  • 소매
  • 전자상거래
  • 병원/클리닉 약국

제8장 동물용 백신 시장 : 지역별, 추정·동향 분석

• 지역 대시보드
• 동물용 백신 시장 점유율(지역별, 2024년, 2030년), 100만 달러
• 지역 전망
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제9장 경쟁 구도

• 시장 진출기업의 분류
• 기업의 시장 포지셔닝 분석/힙 맵 분석
• 기업 프로파일
  • Merck & Co., Inc.
  • Zoetis
  • Virbac
  • Elanco
  • Boehringer Ingelheim Animal Health
  • Phibro Animal Health Corporation
  • Calier
  • Ceva
  • Bimeda Biologicals
  • Neogen Corporation
• 전략 매핑
  • 합병과 인수
  • 파트너십 및 협업
  • 확대
  • 제품 발매
  • 제품 승인
  • 기타
• 기타 주요 인물 일람

KTH

영문 목차

영문목차

Animal Vaccines Market Growth & Trends:

The global animal vaccines market size is expected to reach USD 22.95 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.5% from 2025 to 2030. The growing incidence of food-borne zoonotic diseases and increasing animal husbandry are boosting the demand for vaccines. Certain transmissible diseases such as bird flu and tuberculosis in invertebrate animals can be transferred directly or indirectly to humans. If consumers eat worms via undercooked fish, they can get contaminated with anisakiasis, a human zoonotic infection caused by some species of nematodes.

The increasing outbreaks of cattle disease and the ever-expanding livestock population are the prime factors for the wide acceptance of the ruminants especially cattle vaccines globally. Moreover, rising pet ownership and increasing awareness regarding the health of companion animals are propelling the market growth. Moreover, the increasing number of R&D investments initiated by the companies is one of the key growth factors. Competition in the market is expected to be high during the forecast period. The market is highly fragmented owing to the presence of several small and large players. This results in high competition among small players to sustain their position in the market.

Moreover, companies are increasingly adopting strategies, such as mergers & acquisitions, geographic expansion, and the launch of new products, to grow in the market. For instance, in December 2020, Elanco acquired exclusive global rights from Kindred Biosciences to its monoclonal antibody for Canine Parvovirus (CPV) called KIND-030. This strengthened the company's overall vaccine and therapeutics portfolios. Moreover, in September 2020, Ceva enhanced its production capacity at its French facility for bacterial autogenous vaccines. This is expected to support its growth strategy.

Animal Vaccines Market Report Highlights:

• The attenuated live vaccines segment dominated the market and accounted for a revenue share of over 37.00% in 2024.
• The livestock segment dominated the market with the highest revenue share in 2024. This can be attributed to factors such as the rising livestock population, supportive government initiatives, and the outbreak of diseases among cattle and sheep.
• Hospital/clinic pharmacy held the dominant share of the market in 2024. These facilities are often at the forefront of adopting new technologies.
• The subcutaneous segment dominated the market for animal vaccines, with a revenue share of over 41.0% in 2024.
• North America dominated the market and accounted for a revenue share of over 28% in 2024. The region is expected to remain dominant throughout the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Animal Vaccines Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising livestock population
    • 3.2.1.2. Increasing disease outbreak
    • 3.2.1.3. Rising R&D and manufacturing advancements
    • 3.2.1.4. Growing demand for animal derived food products
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of awareness
    • 3.2.2.2. Complex regulations
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Animal Vaccines Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
  • 3.3.3. Regulatory Framework
  • 3.3.4. Pricing Analysis
  • 3.3.5. Disease Prevalence Analysis
  • 3.3.6. Estimated Animal Population by key countries, key species, 2024
  • 3.3.7. COVID-19 Impact Analysis

Chapter 4. Animal Vaccines Market: Animal Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Animal Vaccines Market: Animal type Movement Analysis
• 4.3. Animal Vaccines Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
• 4.4. Livestock
  • 4.4.1. Livestock Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Poultry
    • 4.4.2.1. Poultry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Aqua
    • 4.4.3.1. Aqua Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Ruminant
    • 4.4.4.1. Ruminant Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.5. Swine
    • 4.4.5.1. Swine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Companion
  • 4.5.1. Companion Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Canine
    • 4.5.2.1. Canine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Feline
    • 4.5.3.1. Feline Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Others
    • 4.5.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Animal Vaccines Market: By Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Animal Vaccines Market: By Product Movement Analysis
• 5.3. Animal Vaccines Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
  • 5.3.1. Attenuated Live Vaccines
    • 5.3.1.1. Attenuated Live Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.2. Inactivated Vaccines
    • 5.3.2.1. Inactivated Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.3. Subunit Vaccines
    • 5.3.3.1. Subunit Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.4. DNA Vaccines
    • 5.3.4.1. DNA Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.5. Recombinant Vaccines
    • 5.3.5.1. Recombinant Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Animal Vaccines Market: By Route of Administration Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Animal Vaccines Market: By Route of Administration Movement Analysis
• 6.3. Animal Vaccines Market Size & Trend Analysis, by route of administration, 2018 to 2030 (USD Million)
  • 6.3.1. Subcutaneous
    • 6.3.1.1. Subcutaneous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. Intramuscular
    • 6.3.2.1. Intramuscular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Intranasal
    • 6.3.3.1. Intranasal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Animal Vaccines Market: By Distribution Channel Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Animal Vaccines Market: By Distribution Channel Movement Analysis
• 7.3. Animal Vaccines Market Size & Trend Analysis, by distribution channel, 2018 to 2030 (USD Million)
  • 7.3.1. Retail
    • 7.3.1.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. E-Commerce
    • 7.3.2.1. E-Commerce Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Hospital/Clinic Pharmacy
    • 7.3.3.1. Hospital/Clinic Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Animal Vaccines Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Animal Vaccines Market Share, By Region, 2024 & 2030, USD Million
• 8.3. Regional Outlook
• 8.4. North America
  • 8.4.1. North America Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. U.S. Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Canada Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Mexico Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. UK Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Germany Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. France Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Italy Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Spain Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Denmark
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Denmark Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Sweden Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Norway Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Japan Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. China Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. India Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Australia Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. South Korea Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Thailand Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Brazil Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Argentina Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.8. Middle East & Africa
  • 8.8.1. Middle East & Africa Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. South Africa Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Saudi Arabia Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. UAE Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Kuwait Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Company Market Position Analysis/ Heap Map Analysis
• 9.3. Company Profiles
  • 9.3.1. Merck & Co., Inc.
    • 9.3.1.1. Participant's Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Product Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Zoetis
    • 9.3.2.1. Participant's Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Product Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Virbac
    • 9.3.3.1. Participant's Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Product Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Elanco
    • 9.3.4.1. Participant's Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Product Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Boehringer Ingelheim Animal Health
    • 9.3.5.1. Participant's Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Product Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Phibro Animal Health Corporation
    • 9.3.6.1. Participant's Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Product Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Calier
    • 9.3.7.1. Participant's Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Product Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Ceva
    • 9.3.8.1. Participant's Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Product Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. Bimeda Biologicals
    • 9.3.9.1. Participant's Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Product Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. Neogen Corporation
    • 9.3.10.1. Participant's Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Product Benchmarking
    • 9.3.10.4. Strategic Initiatives
• 9.4. Strategy Mapping
  • 9.4.1. Mergers & Acquisitions
  • 9.4.2. Partnerships & Collaborations
  • 9.4.3. Expansion
  • 9.4.4. Product launch
  • 9.4.5. Product Approval
  • 9.4.6. Others
• 9.5. List of other key players

관련자료